Research ArticleBrief Communications
Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
Kwadwo Antwi, Melpomeni Fani, Guillaume Nicolas, Christof Rottenburger, Tobias Heye, Jean Claude Reubi, Beat Gloor, Emanuel Christ and Damian Wild
Journal of Nuclear Medicine July 2015, 56 (7) 1075-1078; DOI: https://doi.org/10.2967/jnumed.115.157768
Kwadwo Antwi
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Melpomeni Fani
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Guillaume Nicolas
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Christof Rottenburger
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Tobias Heye
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Jean Claude Reubi
2Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Bern, Switzerland
Beat Gloor
3Department of Visceral Surgery, University Hospital of Bern, Bern, Switzerland; and
Emanuel Christ
4Division of Endocrinology, Diabetology, and Clinical Nutrition, University Hospital of Bern, Bern Switzerland
Damian Wild
1Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Basel, Switzerland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 7
July 1, 2015
Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
Kwadwo Antwi, Melpomeni Fani, Guillaume Nicolas, Christof Rottenburger, Tobias Heye, Jean Claude Reubi, Beat Gloor, Emanuel Christ, Damian Wild
Journal of Nuclear Medicine Jul 2015, 56 (7) 1075-1078; DOI: 10.2967/jnumed.115.157768
Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
Kwadwo Antwi, Melpomeni Fani, Guillaume Nicolas, Christof Rottenburger, Tobias Heye, Jean Claude Reubi, Beat Gloor, Emanuel Christ, Damian Wild
Journal of Nuclear Medicine Jul 2015, 56 (7) 1075-1078; DOI: 10.2967/jnumed.115.157768
Jump to section
Related Articles
Cited By...
- 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism
- Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
- Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
- Optoacoustic imaging of GLP-1 Receptor with a near-infrared exendin-4 analog
- PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for {beta}-Cell Imaging
- The future: surgical advances in MEN1 therapeutic approaches and management strategies
- Molecular imaging in the investigation of hypoglycaemic syndromes and their management
- Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers
- Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
- Radiopeptides for Imaging and Therapy: A Radiant Future